What Is BPC‑157 and What Does It Do?
Body Protection Compound 157 (BPC‑157) is a synthetic peptide chain of 15 amino acids. Originally isolated from a protein in human gastric juice, this peptide is widely studied in preclinical models for its potential to support tissue repair and cellular integrity.
Our BPC-157 capsule’s oral formulation is designed to withstand stomach acid and reach target tissues, where it may help modulate inflammatory responses, promote angiogenesis, and accelerate healing in soft tissue, tendons, and the gastrointestinal tract—though human clinical data remains limited.
Note that any perceived benefits are based on preliminary findings in non-human studies. BPC-157 in all forms is not approved for human or veterinary use.
Observed Effects of BPC‑157 in Preclinical Healing Studies
In vitro and animal models have shown that BPC‑157 may influence multiple systems involved in recovery, tissue regeneration, and inflammatory modulation.
Accelerated Wound Healing
In preclinical studies, BPC-157 has demonstrated impressive wound healing properties, particularly in models of chemical burns and soft tissue damage. It appears to stimulate the formation of granulation tissue, reepithelialization, and collagen deposition, which are key phases in the healing process.
Additionally, BPC-157 promotes angiogenesis, or the development of new blood vessels, which is crucial for delivering nutrients and oxygen to damaged tissue.
This compound may also enhance the migration and proliferation of endothelial cells, further aiding tissue regeneration. These effects make it a promising candidate for future studies on complex wound healing scenarios [1].
Angiogenesis and endothelial cell activation also contribute to tissue regeneration in preclinical models.
Tendon and Ligament Recovery
Animal studies suggest that BPC-157 plays a unique role in supporting the repair of ligaments and tendons, which traditionally suffer from poor blood supply and slow recovery. Research shows that BPC-157 may activate healing cascades that improve fibroblast activity, collagen fiber organization, and functional recovery in tendon rupture and ligament injury models.
These modes of healing have been observed in rodents with transected Achilles tendons [2]. The peptide also seems to counteract the damaging effects of nonsteroidal anti-inflammatory drugs (NSAIDs) and may protect connective tissues from further breakdown.
Muscle and Bone Repair
In preclinical studies, BPC-157 has shown the ability to support muscle regeneration and bone healing. Research suggests it can enhance fibroblast activity, promote vascularization, and increase the expression of genes involved in tissue growth and remodeling [3].
Notably, it may also help reverse muscle wasting and improve functional recovery in cases of injury [4]. For bone tissue, BPC-157 appears to stimulate osteoblast activity and speed up fracture healing, even in compromised conditions like steroid-induced damage. These findings make it a promising peptide for further exploration in musculoskeletal research.
Gastrointestinal Support
BPC-157 originally drew attention for its protective effects on the gastrointestinal tract. In rodent studies, it has shown the ability to accelerate the healing of ulcers, reduce inflammation, and protect the intestinal lining from NSAID-induced damage [5].
It seems to help maintain gut integrity by preserving endothelial function and tight junctions, crucial for a healthy barrier against pathogens and toxins. Additionally, BPC-157 may counteract the effects of harmful agents like alcohol or toxins in the stomach and colon, making it valuable in GI-related research [4].
In particular, capsule-based BPC‑157 may exert localized benefit on the GI tract, especially ulcer healing and maintaining gut barrier integrity. Some oral forms may deliver a more targeted effect to the digestive system itself.
Neuroprotective and Anti‑Inflammatory Properties
Preclinical data suggests BPC-157 may play a neuroprotective role, aiding in nerve regeneration and recovery from central nervous system damage. In rodent studies, it has been shown to support healing after traumatic brain injury, spinal cord injury, and peripheral nerve damage [6].
BPC-157 may influence neurotransmitter systems, including dopamine and serotonin pathways, and may reduce oxidative stress in neural tissue. These findings point to its potential in research related to neural repair, neurodegeneration, and stroke recovery, although human applications remain entirely unstudied at this time [7].
They’re generally regarded as slower in action, with lower overall bioavailability and variable absorption depending on gut conditions.
Evolve Peptides Standards on Peptide Purity
At Evolve Peptides, we know quality issues can skew research outcomes—so our BPC‑157 capsules meet rigorous control standards. We ensure strict synthesis control, encapsulation under sterile conditions, HPLC, mass spectrometry verification, and third‑party testing.
Our capsules, each containing 500 mcg of research-grade BPC‑157, consistently show >99% purity in COAs. We fully disclose batch documentation and support independent verification. If your capsules are sent out for off-site testing, we’ll replace them for free.
Note: Independent Testing Welcome We proudly support third-party testing by our customers. If you’d like to validate the purity of our BPC-157 through an independent lab, we’ll replace any peptide vials used in the process—free of charge. |
Are BPC‑157 Capsules Effective?
Emerging evidence suggests that oral usage of BPC-157 can be effective, particularly because the compound is derived from a naturally occurring peptide in the gastrointestinal system. This origin supports the hypothesis that it can remain stable in the digestive tract and exert therapeutic effects when taken orally.
Anecdotal reports and limited studies indicate positive effects in inflammation, improving gut health, accelerating healing of tendons and ligaments, and mitigating symptoms of gastrointestinal disorders.
The oral formulation can be particularly convenient for researchers.
- As they pass through the digestive system, capsules often require higher total exposure and may take longer to show effects.
However, it is important to note that comprehensive clinical trials in humans are still lacking, and the bioavailability of orally administered BPC-157 remains a topic of ongoing investigation.
When you buy BPC 157 at Evolve Peptides, we expect you to use it for research purposes only and within the recommended guidelines.
Note: While BPC-157 is derived from gastric proteins and appears to be stable in the digestive tract, in clinical settings oral BPC-157 has been taken on an empty stomach to optimize bioavailability and minimize potential interference from food. |
BPC‑157 Peptide Characteristics
- Molecular Formula: C₆₂H₉₈N₁₆O₂₂
- Molar Mass: ~1,419.5 g/mol (also reported as 1,419.56 g/mol)
- Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Synonyms & Related Names:
- BPC 157
- Bepecin
- PL‑14736 (Pliva code)
- Pentadecapeptide BPC‑157
- Body Protection Compound 157
- Database IDs:
- PubChem CID: 9941957
- UniChem ID, ChemSpider: 8117571
- Storage Recommendations:
- Short‑term: Refrigerate at 2–8 °C (36–46 °F).
- Long‑term: Store frozen at ≤ −18 °C (0 °F) or below, sealed and protected from light and moisture.
- Recommended to use promptly after thawing or reconstitution.
BPC‑157 vs. TB‑500 vs. PDA Comparison
Feature | BPC‑157 | TB‑500 | PDA (Pentadecapeptide Arginate) |
Type | Gastric‑derived pentadecapeptide | Synthetic fragment of Thymosin β‑4 | Modified pentadecapeptide (BPC‑157 + arginine) |
Origin | Human gastric juice protein fragment | Thymosin β‑4 (actin‑regulating protein) | Engineered variant for increased stability |
Key Mechanism | Enhances angiogenesis, fibroblast migration, GH‑receptor upregulation | Promotes cell migration and actin reorganization via TB‑4 endogenous | Stimulates angiogenesis via VEGFR2, collagen synthesis, nitric oxide pathways |
Primary Application | Tendon/ligament repair, GI healing, neuroprotection, anti‑inflammation | Musculoskeletal repair, skin wounds, cardiac tissue recovery | Tissue repair (skin, muscle), vascular regeneration, gut/nerve support |
Mechanism Complexity | Moderate—targets multiple healing pathways | Cell‑migration heavy, systemic repair focused | Similar to BPC‑157 with enhanced stability |
Safety / Tolerability | No overt toxicity in animal models, even at high doses | Generally well tolerated in preclinical/clinical settings | Designed for improved stability and tolerance |
Regulatory Status | Research use only; not FDA-approved; prohibited in WADA sports | Research use only; regulatory status similar to BPC‑157 | Not FDA-approved; considered more stable/legal in some countries |
BPC-157 Side Effects in Oral Research Use
BPC-157 is generally regarded as having a favorable safety profile, particularly in preclinical studies involving animals. To date, no severe adverse effects have been consistently documented in research settings.
However, due to the limited number of human studies, particularly long-term evaluations, potential side effects cannot be completely ruled out.
Anecdotal reports occasionally include minor issues such as dizziness, nausea, or changes in appetite. In rare cases, users have reported increased energy levels or restlessness, which may be attributed to the compound’s influence on systemic healing processes or neurotransmitter activity [8].
It is also important to recognize that BPC-157 is not currently approved by the FDA for human use, and products available on the market may vary in purity and potency. For this reason, we encourage you to exercise caution, buy third-party tested products, and consult trusted professionals before use.
BPC-157: Legal Status and Compliance
However, it is legal to purchase and possess in the United States for laboratory research purposes.
We fully expect you to use the BPC-157 you buy from Evolve Peptides within those legal boundaries. By buying from us, you agree to not use the product for self-administration or resale for non-research use.
BPC-157 Certificate of Analysis
Every batch of BPC‑157 capsules we offer undergoes rigorous third‑party laboratory testing to verify purity, identity, and overall quality. We partner with accredited, independent testing facilities to ensure transparency and reliability in every bottle.
- The certificate includes information on:
- Purity percentage, confirmed via HPLC and mass spectrometry
- Peptide identity verification, including molecular weight consistency
- Contaminant screening, such as endotoxin, heavy metals, and microbial contaminants
- Batch and lot number, tied directly to each order for traceability
Upon purchase, each bottle of 120 capsules (500 mcg each) is linked to a dedicated online COA. After placing your order:
- Log in to your account on Evolve Peptides.
- Navigate to your order history.
- Click the link associated with your BPC‑157 capsule batch to download your COA PDF file.
Want to see a sample? You’re welcome to view or download a sample COA PDF directly on our site or request a copy via customer support.
Scientific References
- Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Pavlov KH, Petrovic A, Sikiric S, Vranes H, Prtoric A, Zizek H, Durasin T, Dobric I, Staresinic M, Strbe S, Knezevic M, Sola M, Kokot A, Sever M, Lovric E, Skrtic A, Blagaic AB, Sikiric P. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2021 Jun 29;12:627533. https://pmc.ncbi.nlm.nih.gov/articles/PMC8275860/
- Staresinic, M., Sebecic, B., Patrlj, L., Jadrijevic, S., Suknaic, S., Perovic, D., Aralica, G., Zarkovic, N., Borovic, S., Srdjak, M., Hajdarevic, K., Kopljar, M., Batelja, L., Boban-Blagaic, A., Turcic, I., Anic, T., Seiwerth, S., & Sikiric, P. (2003). Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research, 21(6), 976–983. https://onlinelibrary.wiley.com/doi/pdf/10.1016/S0736-0266(03)00110-4
- Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014 Nov 19;19(11):19066-77. https://pmc.ncbi.nlm.nih.gov/articles/PMC6271067/
- Vukojevic J, Milavić M, Perović D, Ilić S, Čilić AZ, Đuran N, Štrbe S, Zoričić Z, Filipčić I, Brečić P, Seiverth S, Sikirić P. Pentadecapeptide BPC 157 and the central nervous system. Neural Regen Res. 2022 Mar;17(3):482-487. https://pmc.ncbi.nlm.nih.gov/articles/PMC8504390/
- Sikiric P, Hahm KB, Blagaic AB, Tvrdeic A, Pavlov KH, Petrovic A, Kokot A, Gojkovic S, Krezic I, Drmic D, Rucman R, Seiwerth S. Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future. Gut Liver. 2020 Mar 15;14(2):153-167. https://pmc.ncbi.nlm.nih.gov/articles/PMC7096228/
- Vukojević J, Vrdoljak B, Malekinušić D, et al. The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats. Brain Behav. 2020; 10:e01726. https://onlinelibrary.wiley.com/doi/10.1002/brb3.1726
- Sikiric P, Seiwerth S, Rucman R, Kolenc D, Vuletic LB, Drmic D, Grgic T, Strbe S, Zukanovic G, Crvenkovic D, Madzarac G, Rukavina I, Sucic M, Baric M, Starcevic N, Krstonijevic Z, Bencic ML, Filipcic I, Rokotov DS, Vlainic J. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865. https://pmc.ncbi.nlm.nih.gov/articles/PMC5333585/#:~:text=It%20has%20been%20proven%20that,%5D%20and%20opioid%20%5B63%5D
- Xu, C., Sun, L., Ren, F., Huang, P., Tian, Z., Cui, J., … & Li, W. (2020). Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds. Regulatory Toxicology and Pharmacology, 114, 104665.https://www.sciencedirect.com/science/article/abs/pii/S027323002030091X
Save $25.00
Save $90.00